Epidermal growth factor receptor in vulvar malignancies and its relationship to metastasis and patient survival

被引:56
作者
Johnson, GA
Mannel, R
Khalifa, M
Walker, JL
Wren, M
Min, KW
Benbrook, DM
机构
[1] MEM UNIV NEWFOUNDLAND,DEPT PATHOL,ST JOHNS,NF A1C 5S7,CANADA
[2] DEACONESS HOSP,OKLAHOMA CITY,OK 73112
关键词
D O I
10.1006/gyno.1997.4660
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Objective. To evaluate the level of epidermal growth factor receptor (EGF-R) expression in vulvar malignancies and to determine if a correlation exists between EGF-R levels and metastasis or patient survival. Methods. All patients with a diagnosis of invasive squamous cell carcinoma of the vulva who were treated at our institution with a primary radical vulvectomy and inguinal lymph node dissection from 1983 to 1993 were eligible for the study. Sixty-one patients with available tissue blocks of benign vulvar epithelium, the primary malignant vulvar lesion, and groin node metastasis (when positive) were included in the study. Semiquantitative EGF-R expression was determined in a blinded fashion utilizing immunohistochemical staining of appropriate tissue samples. Survival was calculated utilizing Kaplan-Meier life table analysis based upon disease-free survival. Results. A significant increase (P < 0.001) in mean EGF-R levels was demonstrated in the primary tumor (67%) versus benign vulvar epithelium (31%). In the 14 patients with lymph node metastasis, the mean EGF-R level in the primary tumor was 65% versus 88% in the metastatic lesion (P < 0.001). The likelihood of lymph node metastasis was elevated in those patients with a benign tissue EGF-R level greater than or equal to 40% (P < 0.03) and in those patients with a primary tumor EGF-R level greater than or equal to 90% (P < 0.025). Life table analysis revealed a cumulative disease-free survival of 45% for all patients. Disease-free survival in those patients with EGF-R levels greater than or equal to 90% in the primary tumor was 25%, contrasting with a disease-free survival of 54% in those patients with EGF-R levels <90% (P < 0.05). Conclusions. There is a progressive increase in EGF-R expression from benign vulvar epithelium to primary malignant tissue to metastatic lesions within the same patient. Increased expression of EGF-R in the primary vulvar malignancy is significantly associated with lymph node metastasis and decreased patient survival. Increased expression of EGF-R in histologically benign vulvar epithelium has a significant association with lymph node metastasis and may predict decreased patient survival. (C) 1997 Academic Press.
引用
收藏
页码:425 / 429
页数:5
相关论文
共 49 条
[41]  
SHIN DM, 1994, CANCER RES, V54, P3153
[42]   RETINOIDS IN CANCER-THERAPY [J].
SMITH, MA ;
PARKINSON, DR ;
CHESON, BD ;
FRIEDMAN, MA .
JOURNAL OF CLINICAL ONCOLOGY, 1992, 10 (05) :839-864
[43]   Sites of failure and times to failure in carcinoma of the vulva treated conservatively: A gynecologic oncology group study [J].
Stehman, FB ;
Bundy, BN ;
Ball, H ;
ClarkePearson, DL .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1996, 174 (04) :1128-1132
[44]   EPIDERMAL GROWTH-FACTOR RECEPTOR, C-ERBB-2 PROTOONCOGENE AND ESTROGEN-RECEPTOR EXPRESSION IN HUMAN PAPILLOMAVIRUS LESIONS OF THE UTERINE CERVIX [J].
TERVAHAUTA, A ;
SYRJANEN, S ;
SYRJANEN, K .
INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY, 1994, 13 (03) :234-240
[45]   MULTIPARAMETER FLOW-CYTOMETRIC QUANTITATION OF EPIDERMAL GROWTH-FACTOR RECEPTOR AND C-ERBB-2 ONCOPROTEIN IN NORMAL AND NEOPLASTIC TISSUES OF THE FEMALE GENITAL-TRACT [J].
VANDAM, PA ;
LOWE, DG ;
WATSON, JV ;
JAMES, M ;
CHARD, T ;
HUDSON, CN ;
SHEPHERD, JH .
GYNECOLOGIC ONCOLOGY, 1991, 42 (03) :256-264
[46]   THE RELATIONSHIP OF QUANTITATIVE EPIDERMAL GROWTH-FACTOR RECEPTOR EXPRESSION IN NONSMALL CELL LUNG-CANCER TO LONG-TERM SURVIVAL [J].
VEALE, D ;
KERR, N ;
GIBSON, GJ ;
KELLY, PJ ;
HARRIS, AL .
BRITISH JOURNAL OF CANCER, 1993, 68 (01) :162-165
[47]  
Wells A, 1989, Cancer Treat Res, V47, P143
[48]   IMMUNOHISTOCHEMICAL EXPRESSION OF EPIDERMAL GROWTH-FACTOR RECEPTOR IN SALIVARY-GLAND TUMORS [J].
YAMADA, K ;
IWAI, K ;
OKADA, Y ;
MORI, M .
VIRCHOWS ARCHIV A-PATHOLOGICAL ANATOMY AND HISTOPATHOLOGY, 1989, 415 (06) :523-531
[49]  
ZHENG ZS, 1990, CANCER RES, V50, P1201